companydata.dkcompanydata.dk

UNILABS A/S: Financial statements 2022

CVR: 29458219

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

UNILABS A/S (CVR 29458219) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 67,790,000 and a net result of DKK 18,190,000 compared with DKK 16,124,000 the year before. That is an increase of 13.2% compared with the year before. Equity in the 2022 report amounted to DKK 140,079,000. The solvency ratio was 78.8%. The company had 48 employees in the financial year.

Gross Profit
DKK 67,790,000
Profit/Loss
DKK 18,190,000
Equity
DKK 140,079,000
Total Assets
DKK 177,781,000
Employees
48

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-67.8 mio.18.2 mio.140.1 mio.48
2021-59.9 mio.16.1 mio.121.9 mio.55
2020-50 mio.9.3 mio.105.8 mio.59
2019-53.6 mio.12.1 mio.96.5 mio.80
2018-52.7 mio.12.1 mio.84.3 mio.75

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on UNILABS A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Shalinee Basak joins the board of UNILABS A/SSep 15, 2022

As of September 15, 2022, Shalinee Basak has joined the board of directors of UNILABS A/S.

Samantha Laurent leaves the board of UNILABS A/SSep 15, 2022

As of September 15, 2022, Samantha Laurent has left the board of directors of UNILABS A/S.

UNILABS A/S: The 2021 annual report is outJul 5, 2022

UNILABS A/S has published its annual report for 2021. Gross profit came to DKK 59,903,000, and the net result was DKK 16,124,000.

About UNILABS A/S

UNILABS A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1969. The company is registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The company was previously named CAPIO DIAGNOSTIK A/S and NOVA MEDICAL MEDI-LAB A/S. The management consists of Amar Rauf. The board consists of Thomas Axel Per Lindahl (chair), Amar Rauf and Eric Schuh. The company is owned by Unilabs Laboratoire d'Analyses Médicales SA. The company has 47 employees (2026). In 2025, the company reported a gross profit of DKK 74,330,000 and a net result of DKK 37,726,000 compared with DKK 44,593,000 the year before. Equity in the 2025 report amounted to DKK 90,050,000.

Source: annual report 2025, Danish Business Authority